PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1808090
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1808090
The European infection control market is projected to reach USD 20.58 billion by 2030 from USD 14.99 billion in 2025, at a CAGR of 6.6% during the forecast period.
Scope of the Report | |
---|---|
Years Considered for the Study | 2024-2030 |
Base Year | 2024 |
Forecast Period | 2025-2030 |
Units Considered | Value (USD billion) |
Segments | Product & Service and End User |
Regions covered | Germany, the UK, France, Italy, Spain, Switzerland, Poland, Austria, Romania, the Czech Republic, Slovakia, Portugal, and the Rest of Europe (RoE) |
The European infection control market is projected to grow at a CAGR of 6.6% during the forecast period. The growth of the market is fuelled by the growing number of surgeries, advancements in reprocessing technologies, the increasing emphasis on sterilization & disinfection of food, advancements in sterilization equipment technology, and the rising trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals.
By product & service, the cleaning & disinfection products segment accounted for the largest share of the market in 2024.
By product & service, the European infection control market is segmented into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and other infection control products. In 2024, the cleaning & disinfection products segment accounted for the largest share of the European infection control market. The large share of this segment is attributed to the rising incidence of chronic diseases, stringent regulatory standards, advancements in sterilization technologies, and the favourable government support for healthcare procedures.
By end user, the hospitals & clinics segment accounted for the largest share of the market in 2024.
Based on end users, the European infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, the life sciences industry, the food industry, and other end users. The hospitals & clinics segment accounted for the largest share of the European infection control market in 2024. The increasing number of surgical procedures and government initiatives to improve infection prevention and control have prompted greater awareness and implementation of rigorous standards.
By country, Germany is expected to dominate the European infection control market during the forecast period.
The European infection control market is segmented into 13 countries: Germany, the UK, France, Italy, Spain, Switzerland, Poland, Austria, Romania, the Czech Republic, Slovakia, Portugal, and the rest of Europe. Germany is projected to dominate the market during the forecast period, owing to several reinforcing factors such as strong regulatory backing through national public health initiatives and infection control programs; high healthcare expenditure; and adoption of technologically advanced infection control products, including automated disinfection systems and professional training protocols.
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the European infection control market are STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), Solventum Corporation (US), Advanced Sterilization Products (US), Kimberly Clark Corporation (US), B. Braun Group (Germany), Olympus Corporation (Japan), Paul Hartmann AG (Germany), Reckitt Benckiser (UK), Cardinal Health (US), Miele Group (Germany), MMM Group (Germany), MATACHANA GROUP (Spain), and Medline Industries, LP (US), among others.
Research Coverage
This report studies the European infection control market based on product & service, end user, and countries. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Additionally, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments in 13 countries.
Reasons to Buy the Report
The report will enable established and entrant/smaller firms to gauge the market's pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.